Glen Macdonald Biography and Net Worth

CTO of Sesen Bio

Glen C. MacDonald, Ph.D., serves as Sesen Bio’s chief technology officer. Previously, Dr. MacDonald served Sesen Bio’s predecessor company in several research related capacities from 1997 to 2005. Prior to joining Sesen Bio, Dr. MacDonald held a Manitoba Cancer Treatment Research Foundation Fellowship from 1996 to 1997 while serving as a post-doctoral fellow at the University of Manitoba Cancer Treatment Research Foundation from 1995 to 1997. Dr. MacDonald also served as a Canadian Arthritis Society post-doctoral fellow at the University of North Carolina at Chapel Hill from 1993 to 1995. He graduated from the University of Guelph with a bachelor’s degree in genetics in 1980 and earned an M.Sc. and Ph.D. from the University of Manitoba in 1987 and 1993, respectively. Dr. MacDonald’s scientific background is extensive, having published in the areas of monoclonal antibodies, graft versus-host disease, lupus and apoptosis.

What is Glen C. Macdonald's net worth?: The estimated net worth of Glen C. Macdonald is at least $0.00 as of March 2nd, 2023. Dr. Macdonald owns 10,337 shares of Sesen Bio stock worth more than $0 as of April 27th. This net worth approximation does not reflect any other assets that Dr. Macdonald may own. Learn More about Glen C. Macdonald's net worth.
How do I contact Glen C. Macdonald?: The corporate mailing address for Dr. Macdonald and other Sesen Bio executives is 245 FIRST STREET SUITE 1800, CAMBRIDGE MA, 02142. Sesen Bio can also be reached via phone at (617) 444-8550 and via email at [email protected]. Learn More on Glen C. Macdonald's contact information.
Has Glen C. Macdonald been buying or selling shares of Sesen Bio?: Glen C. Macdonald has not been actively trading shares of Sesen Bio during the last quarter. Most recently, Glen C. Macdonald sold 8,518 shares of the business's stock in a transaction on Thursday, March 2nd. The shares were sold at an average price of $11.80, for a transaction totalling $100,512.40. Following the completion of the sale, the chief technology officer now directly owns 10,337 shares of the company's stock, valued at $121,976.60. Learn More on Glen C. Macdonald's trading history.
Who are Sesen Bio's active insiders?: Sesen Bio's insider roster includes Thomas Cannell (CEO), Monica Forbes (CFO), Glen Macdonald (CTO), and Mark Sullivan (General Counsel). Learn More on Sesen Bio's active insiders.

Glen C. Macdonald Insider Trading History at Sesen Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/2/2023	Sell	8,518	$11.80	$100,512.40	10,337
2/21/2023	Sell	1,296	$11.80	$15,292.80	14,149

Glen C. Macdonald Buying and Selling Activity at Sesen Bio

Sesen Bio Company Overview

Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.

Today's Range

Now: N/A

50 Day Range

MA: $10.50

$0.63

$12.99

2 Week Range

Now: N/A

Volume

93,330 shs

Average Volume

1,067,298 shs

Market Capitalization

$2.56 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.83

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

From Colonial Metals | Ad

See why the elites are pouring billions into gold.